Impossible Foods Wins Ruling to Continue Use of Key Additive
(Bloomberg) -- Impossible Foods won a court ruling that allows it to continue using a key additive in its popular meat substitute over the objections of a food safety group.
The federal appeals court in San Francisco on Monday upheld a decision by the U.S. Food and Drug Administration to approve the use of soy leghemoglobin as a color additive in Impossible's imitation beef patties. The 2019 decision removed a hurdle for Impossible in extending its burger sales from restaurants to grocery stores.
Soy leghemoglobin, or “heme,” is a red, genetically modified ingredient that Impossible has long touted as the key to the Impossible Burger's flavor. But its use has brought regulatory problems in the U.S. and barred the products from major foreign markets, including China and the European Union. Beyond Meat Inc., Impossible's main competitor, often points to its GMO-free ingredient list in its marketing.
The market for plant-based meat is forecast to grow to $450 billion, making up a quarter of the $1.8 trillion meat market, by 2040, according to consulting firm Kearney, which sees animal protein peaking in 2025.
Read More: America's Biggest Meat Company Gives Faux Burgers Another Shot
In its ruling, the court denied the Center for Food Safety's request to overturn the FDA decision. Two judges said the FDA had applied the correct standard in reviewing the safety of soy leghemoglobin and that the agency's decision was supported by “substantial evidence.” They also said the FDA could rely on a study commissioned by Impossible. The third judge declined to consider whether CFS had raised valid concerns, saying the group lacked standing to challenge the FDA's decision.
“We are disappointed by the court's ruling today, which will allow Impossible Burger and other meatless burgers to be made with a novel genetically engineered chemical without conducting any long-term health studies,” Sylvia Wu, a senior attorney with CFS, said in a statement. “FDA is supposed to protect consumers from unsafe novel chemicals in our food supply, instead now consumers bear the burden of avoiding these GMO plant-based burgers.”
The case is Center for Food Safety v. FDA, 20-70747, U.S. Court of Appeals, Ninth Circuit (San Francisco).
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.